CoChat

HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses

Open access

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Abstract

Approximately 50% of cancer patients receive radiation treatment, either alone or in combination with other therapies. Tumor hypoxia has long been associated with resistance to radiation therapy. Moreover, the expression of hypoxia inducible factors HIF1α and/or HIF2α correlates with poor prognosis in many tumors. Recent evidence indicates that HIF1α expression can enhance radiation-induced apoptosis in cancer cells. We demonstrate here that HIF2α inhibition promotes tumor cell death and, in contrast to HIF1α, enhances the response to radiation treatment. Specifically, inhibiting HIF2α expression augments p53 activity, increases apoptosis, and reduces clonogenic survival of irradiated and non-irradiated cells. Moreover, HIF2α inhibition promotes p53-mediated responses by disrupting cellular redox homeostasis, thereby permitting reactive oxygen species (ROS) accumulation and DNA damage. These results correlate with altered p53 phosphorylation and target gene expression in untreated human tumor samples and show that HIF2α likely contributes to tumor cell survival including during radiation therapy.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0907357106

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Cited by

See all 198

Metadata

Authors
Bertout, J. A., Majmundar, A. J., Gordan, J. D., Lam, J. C., Ditsworth, D., Keith, B., Brown, E. J., Nathanson, K. L., & Simon, M. C.
Affiliations
  • Abramson Cancer Center (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
Simon, M. Celeste
Venue
Proceedings of the National Academy of Sciences
Published
2009-08-25
Volume
106
Issue
34
Pages
14391-14396
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2009520390
Cited by
196
References
33
Citations by year
2026: 5 · 2025: 2 · 2024: 7 · 2023: 7 · 2022: 13 · 2021: 20 · 2020: 8 · 2019: 9 · 2018: 13 · 2017: 10 · 2016: 16 · 2015: 20 · 2014: 11 · 2013: 15 · 2012: 10
FWCI
4.47
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Cancer Institute (P01CA104838, CA104838, R25CA101871)
  • Abramson Family Cancer Research Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
HIF-2α, HIF-1α, p53 pathway, radiotherapy response, tumor hypoxia, apoptosis, redox homeostasis, reactive oxygen species, DNA damage, p53 phosphorylation, clonogenic survival, radiosensitivity
MeSH terms
Endothelial PAS Domain-Containing Protein 1, Cell Cycle, DNA Damage, Humans, Microscopy, Fluorescence, Neoplasms, Proto-Oncogene Proteins, Radiation, Ionizing, Immunoblotting, Signal Transduction, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Cell Death, Reactive Oxygen Species, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, RNA Interference, Cell Line, Tumor, Apoptosis Regulatory Proteins, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Caspase 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. https://app.cochat.ai/papers/10.1073/pnas.0907357106
The paper
Bertout, J. A., Majmundar, A. J., Gordan, J. D., Lam, J. C., Ditsworth, D., Keith, B., Brown, E. J., Nathanson, K. L., & Simon, M. C. (2009). HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0907357106

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.